Clinical Trials
5 trialsNCT06982287 2025-07-08
A Retrospective Real-World Study on the Efficacy and Safety of Anlotinib Hydrochloride Combined With Immunotherapy Maintenance Therapy Following Standard Chemoimmunotherapy for ES-SCLC (ALTER-L059)
Sir Run Run Shaw Hospital
Not yet recruiting
NCT07022301 2025-06-15
Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy
First Affiliated Hospital of Wannan Medical College
Phase 2 Not yet recruiting
NCT06851819 2025-02-28
TERE
Hebei Medical University Fourth Hospital
Phase 2 Not yet recruiting
NCT06825208 2025-02-13
Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial
Nanjing First Hospital, Nanjing Medical University
Not yet recruiting
NCT05066945 2021-10-04
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
Xiangya Hospital of Central South University
Not yet recruiting